IDT logo

IDT Australia Limited Stock Price

ASX:IDT Community·AU$21.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IDT Share Price Performance

AU$0.051
-0.06 (-53.64%)
AU$0.051
-0.06 (-53.64%)
Price AU$0.051

IDT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
0 Rewards

IDT Australia Limited Key Details

AU$19.8m

Revenue

AU$10.1m

Cost of Revenue

AU$9.7m

Gross Profit

AU$17.8m

Other Expenses

-AU$8.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.019
49.04%
-40.79%
47.5%
View Full Analysis

About IDT

Founded
1975
Employees
n/a
CEO
n/a
WebsiteView website
en.idtaus.com.au

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

Recent IDT News & Updates

Recent updates

No updates